Literature DB >> 7260900

Pharmacological disposition and metabolic fate of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mice and rats.

T C Chou, A Feinberg, A J Grant, P Vidal, U Reichman, K A Watanabe, J J Fox, F S Philips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7260900

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  10 in total

1.  Experimental combination chemotherapy with thymidylate synthetase and ribonucleotide reductase inhibitors.

Authors:  S Kobayashi; T Hoshino; D V Santi
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

2.  Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts.

Authors:  W Lewis; E S Levine; B Griniuviene; K O Tankersley; J M Colacino; J P Sommadossi; K A Watanabe; F W Perrino
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

3.  Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.

Authors:  R F Schinazi; J J Fox; K A Watanabe; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

Review 4.  Antiherpes drugs: promises and pitfalls.

Authors:  E de Clercq
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

5.  Comparison of cell-labeling methods with ¹²⁴I-FIAU and ⁶⁴Cu-PTSM for cell tracking using chronic myelogenous leukemia cells expressing HSV1-tk and firefly luciferase.

Authors:  Jae-Jun Park; Tae-Sup Lee; Jin-Ju Son; Kwon-Soo Chun; In-Ho Song; Yong-Serk Park; Kwang-Il Kim; Yong-Jin Lee; Joo-Hyun Kang
Journal:  Cancer Biother Radiopharm       Date:  2012-09-25       Impact factor: 3.099

6.  Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers.

Authors:  R R Bowsher; J A Compton; J A Kirkwood; G D Place; C D Jones; T E Mabry; D L Hyslop; B L Hatcher; K A DeSante
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

7.  Delayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis.

Authors:  R F Schinazi; T C Chou; R T Scott; X J Yao; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

8.  Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections.

Authors:  A Feinberg; B Leyland-Jones; M P Fanucchi; C Hancock; J J Fox; K A Watanabe; P M Vidal; L Williams; C W Young; F S Philips
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

9.  Inosine analogs as anti-leishmanial agents.

Authors:  P Rainey; P A Nolan; L B Townsend; R K Robins; J J Fox; J A Secrist Iii; D V Santi
Journal:  Pharm Res       Date:  1985-09       Impact factor: 4.200

10.  Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells.

Authors:  L Cui; S Yoon; R F Schinazi; J P Sommadossi
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.